Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale Principal Accounting Officer sold 350 shares at $18.78 ($6,573)
  2. 4 Open-market sale EVP, Chief Financial Officer sold 577 shares at $18.78 ($10,836)
  3. 4 Open-market sale CEO sold 3,851 shares at $18.78 ($72,322)
  4. 4 Open-market sale EVP,General Counsel, Secretary sold 803 shares at $18.78 ($15,080)
  5. 4 Open-market sale EVP, COO, Head of Commercial sold 461 shares at $18.78 ($8,658)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 12,500 shares at $18.25 ($228,125)
  9. 4 Option exercise Director acquired 30,000 shares (option exercise)
  10. 4 Open-market sale CEO sold 3,904 shares at $17.13 ($66,877)
  11. 4 Open-market sale EVP, COO, Head of Commercial sold 532 shares at $17.13 ($9,113)
  12. 4 Open-market sale EVP,General Counsel, Secretary sold 589 shares at $17.13 ($10,090)
  13. 4 Open-market sale President sold 1,847 shares at $15.07 ($27,834)
  14. 4 Open-market sale President sold 1,326 shares at $15.81 ($20,964)
  15. 4 Open-market sale CEO sold 2,804 shares at $15.81 ($44,331)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale EVP, Chief Financial Officer sold 653 shares at $17.91 ($11,695)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 35 · 686 filings